GlassScriptPhysician profile
Shikha Rao
NPI 1093201162
$402.33
in general payments reported to CMS, 2019-2025
15 companies · $54.36 in 2025
The $54.36 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.85 · 2023: $307 · 2024: $26.78 · 2025: $54.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $54.36 | 2025 | Cardiomems |
| Regeneron Healthcare Solutions, INC. | $47.12 | 2023-2024 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $45.05 | 2023 | |
| Genzyme Corporation | $40.68 | 2023 | |
| Lilly USA, LLC | $40.33 | 2023 | Taltz, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $31.37 | 2023 | Sotyktu |
| Organogenesis INC. | $18.52 | 2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.30 | 2023 | Jublia |
| Dermavant Sciences, INC. | $16.81 | 2023 | Vtama |
| Biofrontera INC. | $16.69 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Sun Pharmaceutical Industries INC. | $16.36 | 2023 | Winlevi |
| Amgen INC. | $15.90 | 2023 | Otezla |
| Epi Health, LLC | $13.85 | 2022 | |
| Pfizer INC. | $13.84 | 2023 | |
| Journey Medical Corporation | $13.15 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shikha Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.